Wellington Shields & Co. LLC lessened its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 21.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 32,535 shares of the company’s stock after selling 8,626 shares during the period. Express Scripts makes up approximately 1.7% of Wellington Shields & Co. LLC’s holdings, making the stock its 15th largest position. Wellington Shields & Co. LLC’s holdings in Express Scripts were worth $3,091,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Landaas & Co. WI ADV acquired a new position in Express Scripts in the 2nd quarter valued at approximately $102,000. Kaizen Advisory LLC raised its holdings in Express Scripts by 147.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after acquiring an additional 800 shares in the last quarter. Adviser Investments LLC raised its holdings in Express Scripts by 321.9% in the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after acquiring an additional 1,130 shares in the last quarter. TRUE Private Wealth Advisors acquired a new position in Express Scripts in the 3rd quarter valued at approximately $115,000. Finally, Sun Life Financial INC raised its holdings in Express Scripts by 758.8% in the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock valued at $117,000 after acquiring an additional 1,343 shares in the last quarter. 84.20% of the stock is owned by institutional investors and hedge funds.

In related news, Director Mahon Thomas P. Mac sold 5,234 shares of the stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total transaction of $520,783.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.79% of the stock is owned by corporate insiders.

NASDAQ ESRX opened at $98.48 on Friday. The company has a market cap of $56.09 billion, a P/E ratio of 13.87, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. Express Scripts Holding Co has a one year low of $59.17 and a one year high of $100.43. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.65 and a current ratio of 0.77.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, topping the Zacks’ consensus estimate of $2.42 by $0.01. The business had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. Express Scripts’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the prior year, the company earned $2.51 EPS. Analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current fiscal year.

ESRX has been the topic of several analyst reports. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. Credit Suisse Group lowered Express Scripts from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Royal Bank of Canada upped their price objective on Express Scripts to $94.00 and gave the company an “outperform” rating in a research note on Monday, August 27th. Finally, Mizuho set a $101.00 price objective on Express Scripts and gave the company a “hold” rating in a research note on Monday, November 5th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Express Scripts presently has an average rating of “Hold” and a consensus price target of $89.07.

COPYRIGHT VIOLATION WARNING: “Express Scripts Holding Co (ESRX) Shares Sold by Wellington Shields & Co. LLC” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2018/11/10/express-scripts-holding-co-esrx-shares-sold-by-wellington-shields-co-llc.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Read More: Bull Market

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.